Clear
Paradigm Health Announces Collaboration with the FDA to Transform Regulatory Review of Clinical Trial Data
The initiative will be implemented in two trials, using Paradigm Health’s integrated technology platform to accelerate FDA review.
FDA Approves IsoPSA® — Cleveland Diagnostics’ Novel Blood-Based Prostate Cancer Test
IsoPSA Test Evaluates Prostate Cancer-Specific Structural Variants of the PSA Protein to Aid in the Diagnosis of High-Grade Prostate Cancer
FDA Clears Cionic Neural Sleeve 2, Ushering in a New Era in Mobility Care
The second-generation wearable neurotech is the only system to improve walking by simultaneously activating muscle movement and relaxing muscle spasms through AI-powered stimulation
Neuros Medical Secures $56M Series D to Commercialize the Altius® System, an FDA-Approved, Non-Opioid Nerve Stimulation System for Chronic Post-Amputation Pain
Neuros Medical, Inc., the maker of the Altius® Direct Electrical Nerve Stimulation System, an FDA-approved, breakthrough non-opioid treatment for chronic post-amputation pain, today announced the closing of an oversubscribed $56 million Series D financing round.
PrevNext 
